Zobrazeno 1 - 10
of 55
pro vyhledávání: '"JieYan Shen"'
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-9 (2024)
Abstract Background Pulmonary arterial hypertension (PAH) is a relatively rare but severe disease with a poor prognosis. Pulmonary embolism (PE) is a serious condition that can cause sudden death. Epigenetic age acceleration (EAA) is a robust indicat
Externí odkaz:
https://doaj.org/article/9c1d1c6dc7094cfd87af84b66a399c28
Autor:
An Wang, Mengqi Chen, Qi Zhuang, Lihua Guan, Weiping Xie, Lan Wang, Wei Huang, Zhaozhong Cheng, Shiyong Yu, Hongmei Zhou, Jieyan Shen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/170ae58b5a8942b1817d390dec61fb78
Autor:
Li Huang, Lingpin Pang, Qing Gu, Tao Yang, Wen Li, Ruilin Quan, Weiqing Su, Weifeng Wu, Fangming Tang, Xiulong Zhu, Jieyan Shen, Jingzhi Sun, Guangliang Shan, Changming Xiong, Shian Huang, Jianguo He, Yanjie Yin, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 15, Pp 1837-1845 (2022)
Abstract. Background:. Coronary artery disease (CAD) is the commonest cause of heart failure (HF), whereas pulmonary hypertension (PH) has not been established or reported in this patient population. Therefore, we assessed the prevalence, risk factor
Externí odkaz:
https://doaj.org/article/66f72fec43724b9aaef6684737316f2e
Autor:
An Wang, Mengqi Chen, Qi Zhuang, Lihua Guan, Weiping Xie, Lan Wang, Wei Huang, Zhaozhong Cheng, Shiyong Yu, Hongmei Zhou, Jieyan Shen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundMany retrospective studies suggest that risk improvement may be a suitable efficacy surrogate endpoint for pulmonary arterial hypertension (PAH) medication trials. This prospective multicenter study assessed the efficacy of domestic ambrise
Externí odkaz:
https://doaj.org/article/92cfd3d7289c4e60b57314886cb5b2ad
Autor:
Ruilin Quan, Shian Huang, Lingpin Pang, Jieyan Shen, Weifeng Wu, Fangming Tang, Xiulong Zhu, Weiqing Su, Jingzhi Sun, Zaixin Yu, Lemin Wang, Xianyang Zhu, Changming Xiong, Jianguo He
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background There is no generally accepted comprehensive risk prediction model cooperating risk factors associated with heart failure and pulmonary hemodynamics for patients with pulmonary hypertension due to left heart disease (PH-LHD). We a
Externí odkaz:
https://doaj.org/article/98b30a04ffe048e78f0ea072eee5e742
Autor:
Jian Wang, Chao Ni, Menghui Yang, Xueming Zhang, Binqian Ruan, Lingyue Sun, Xuedong Shen, Jieyan Shen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectivesPressure-strain loop (PSL) is a novel method to quantify myocardial work in many cardiovascular diseases. To investigate the value of myocardial work parameters derived from PSL for evaluating cardiac function and clinical prognosis in pati
Externí odkaz:
https://doaj.org/article/789558f4f4144a3c88c0d188195a9df8
Autor:
Yangyi Lin, Lingpin Pang, Shian Huang, Jieyan Shen, Weifeng Wu, Fangming Tang, Weiqing Su, Xiulong Zhu, Jingzhi Sun, Ruilin Quan, Tao Yang, Huijun Han, Jianguo He
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundPulmonary hypertension due to left heart failure (PH-LHF) is currently the most common form of pulmonary hypertension (PH) encountered in clinical practice. Despite significant advances that have improved our understanding of PH-LHF over th
Externí odkaz:
https://doaj.org/article/48243bd4748844f68a9af9ed1f98be5e
Autor:
Yangyi Lin, Lingpin Pang, Shian Huang, Jieyan Shen, Weifeng Wu, Fangming Tang, Weiqing Su, Xiulong Zhu, Jingzhi Sun, Ruilin Quan, Tao Yang, Huijun Han, Jianguo He
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundPatients with left heart failure (LHF) are often associated with the development of pulmonary hypertension (PH) which leads to an increased risk of death. Recently, the diagnostic standard for PH has changed from mean pulmonary arterial pre
Externí odkaz:
https://doaj.org/article/37a86fc245384875b55531ff8de29df1
Autor:
Ruilin Quan, Yuanhua Yang, Zhenwen Yang, Hongyan Tian, Shengqing Li, Jieyan Shen, Yingqun Ji, Gangcheng Zhang, Caojin Zhang, Guangyi Wang, Yuhao Liu, Zhaozhong Cheng, Zaixin Yu, Zhiyuan Song, Zeqi Zheng, Wei Cui, Yucheng Chen, Shuang Liu, Xiaoxi Chen, Yuling Qian, Changming Xiong, Guangliang Shan, Jianguo He
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background At present, there is no generally accepted comprehensive prognostic risk prediction model for medically treated chronic thromboembolic pulmonary hypertension (CTEPH) patients. Methods Consecutive medically treated CTEPH patients w
Externí odkaz:
https://doaj.org/article/6099fc8c145547d486ca698ba68c3e98
Publikováno v:
Archives of Medical Science, Vol 19, Iss 6, Pp 1879-1888 (2020)
Introduction Idiopathic pulmonary arterial hypertension (IPAH) is a rare and sporadic form of pulmonary arterial hypertension (PAH), characterized by elevated pulmonary arterial resistance leading to right heart failure. However, molecular mechanisms
Externí odkaz:
https://doaj.org/article/bcf73e7807db451bafda8e63f082ca00